Development and pathology of pulmonary hypertension.

[1]  P. Thistlethwaite,et al.  Identification of putative endothelial progenitor cells (CD34+CD133+Flk-1+) in endarterectomized tissue of patients with chronic thromboembolic pulmonary hypertension. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[2]  F. Maldonado,et al.  Medical and Surgical Management of Chylothorax, a Review of 74 Consecutive Cases. , 2009, ATS 2009.

[3]  W. Grizzle,et al.  Histopathological Assessment of the First 9 Cases Collected by the Pulmonary Hypertension Breakthrough Initiative (PHBI). , 2009, ATS 2009.

[4]  W. Grizzle,et al.  Systematic Collection of Human Pulmonary Arterial Hypertension Lung Tissue: Methods of the Pulmonary Hypertension Breakthrough Initiative (PHBI). , 2009, ATS 2009.

[5]  A. Klein,et al.  Pulmonary endarterectomy , 2008, Current opinion in anaesthesiology.

[6]  The hyperproliferative endothelial cell phenotype in idiopathic pulmonary arterial hypertension. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[7]  S. Erzurum,et al.  Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[8]  S. Abman,et al.  Hyperoxia reduces bone marrow, circulating, and lung endothelial progenitor cells in the developing lung: implications for the pathogenesis of bronchopulmonary dysplasia. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[9]  Y. Shang,et al.  Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial. , 2007, Journal of the American College of Cardiology.

[10]  R. Tuder,et al.  Pathology of pulmonary hypertension. , 2007, Clinics in chest medicine.

[11]  W. Vainchenker,et al.  Effects of bone marrow-derived cells on monocrotaline- and hypoxia-induced pulmonary hypertension in mice , 2007, Respiratory research.

[12]  Raed A Dweik,et al.  Alterations of cellular bioenergetics in pulmonary artery endothelial cells , 2007, Proceedings of the National Academy of Sciences.

[13]  David O. Martin,et al.  Pulmonary vein total occlusion following catheter ablation for atrial fibrillation: clinical implications after long-term follow-up. , 2006, Journal of the American College of Cardiology.

[14]  P. Thistlethwaite,et al.  Molecular biology of chronic thromboembolic pulmonary hypertension. , 2006, Seminars in thoracic and cardiovascular surgery.

[15]  A. Nicholson,et al.  Pulmonary Veno-occlusive Disease and Pulmonary Capillary Hemangiomatosis: A Clinicopathologic Study of 35 Cases , 2006, The American journal of surgical pathology.

[16]  T. Stevens.  Molecular and cellular determinants of lung endothelial cell heterogeneity. , 2005, Chest.

[17]  A. Zaiman,et al.  One hundred years of research in the pathogenesis of pulmonary hypertension. , 2005, American journal of respiratory cell and molecular biology.

[18]  S. Archer,et al.  Vascular Endothelial Growth Factor Gene Therapy Increases Survival, Promotes Lung Angiogenesis, and Prevents Alveolar Damage in Hyperoxia-Induced Lung Injury: Evidence That Angiogenesis Participates in Alveolarization , 2005, Circulation.

[19]  M. Yoder,et al.  Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. , 2005, Blood.

[20]  K. Stenmark,et al.  Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia. , 2005, Annual review of physiology.

[21]  S. Dimmeler,et al.  Endothelial Progenitor Cells: Characterization and Role in Vascular Biology , 2004, Circulation research.

[22]  Troy Stevens,et al.  On lung endothelial cell heterogeneity. , 2004, Microvascular research.

[23]  M. Humbert,et al.  Pathologic assessment of vasculopathies in pulmonary hypertension. , 2004, Journal of the American College of Cardiology.

[24]  Paolo Prandoni,et al.  Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. , 2004, The New England journal of medicine.

[25]  M. Frid,et al.  Hypoxia-induced pulmonary artery adventitial remodeling and neovascularization: contribution of progenitor cells. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[26]  R. Budhiraja,et al.  Endothelial Dysfunction in Pulmonary Hypertension , 2004, Circulation.

[27]  S. Phan,et al.  Bone marrow-derived progenitor cells in pulmonary fibrosis. , 2004, The Journal of clinical investigation.

[28]  A. Verin,et al.  Molecular Mechanisms of Thrombin-Induced Endothelial Cell Permeability , 2004, Biochemistry (Moscow).

[29]  W. Seeger,et al.  Circulating Vascular Progenitor Cells Do Not Contribute to Compensatory Lung Growth , 2003, Circulation research.

[30]  P. Thistlethwaite,et al.  Operative classification of thromboembolic disease determines outcome after pulmonary endarterectomy. , 2002, The Journal of thoracic and cardiovascular surgery.

[31]  N. Voelkel,et al.  Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[32]  R. Watkins,et al.  Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[33]  R. Watkins,et al.  Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. , 2001, American journal of respiratory and critical care medicine.

[34]  S. Abman.  Bronchopulmonary dysplasia: "a vascular hypothesis". , 2001, American journal of respiratory and critical care medicine.

[35]  P. Hirth,et al.  Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death‐dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  P. Friedman,et al.  Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension. A morphometric and immunohistochemical study. , 2000, American journal of respiratory and critical care medicine.

[37]  R. Bland,et al.  Chronic Lung Disease in Early Infancy , 2000 .

[38]  N. Voelkel,et al.  Inhibition of angiogenesis decreases alveolarization in the developing rat lung. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[39]  A. Hislop,et al.  Prenatal origins of human intrapulmonary arteries: formation and smooth muscle maturation. , 2000, American journal of respiratory cell and molecular biology.

[40]  J. Shannon,et al.  Tissue interactions mediate early events in pulmonary vasculogenesis , 2000, Developmental dynamics : an official publication of the American Association of Anatomists.

[41]  J. Coalson.  5. PATHOLOGY OF CHRONIC LUNG DISEASE OF EARLY INFANCY , 2000 .

[42]  D. Stewart,et al.  Cell-based gene transfer to the pulmonary vasculature: Endothelial nitric oxide synthase overexpression inhibits monocrotaline-induced pulmonary hypertension. , 1999, American journal of respiratory cell and molecular biology.

[43]  G. Simonneau,et al.  Lung perfusion scans and hemodynamics in acute and chronic pulmonary embolism. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[44]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[45]  A. Hirsch,et al.  Unilateral pulmonary artery thrombotic occlusion: is distal arteriopathy a consequence? , 1996, American journal of respiratory and critical care medicine.

[46]  C. Wagenvoort,et al.  Primary Pulmonary Hypertension: A Pathologic Study of the Lung Vessels in 156 Clinically Diagnosed Cases , 1970 .